REIT - Residential
Compare Stocks
5 / 10Stock Comparison
VRE vs WELL vs EQR vs AVB vs UDR
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Residential
REIT - Residential
REIT - Residential
VRE vs WELL vs EQR vs AVB vs UDR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Residential | REIT - Healthcare Facilities | REIT - Residential | REIT - Residential | REIT - Residential |
| Market Cap | $1.78B | $149.25B | $24.68B | $25.85B | $12.04B |
| Revenue (TTM) | $291M | $11.63B | $3.12B | $3.04B | $1.72B |
| Net Income (TTM) | $70M | $1.43B | $954M | $1.05B | $491M |
| Gross Margin | 23.4% | 39.1% | 46.3% | 67.0% | 46.0% |
| Operating Margin | 14.7% | 4.4% | 28.5% | 30.1% | 27.4% |
| Forward P/E | 23.7x | 78.4x | 50.6x | 37.7x | 66.1x |
| Total Debt | $1.37B | $21.38B | $8.78B | $9.33B | $6.19B |
| Cash & Equiv. | $14M | $5.03B | $56M | $187M | $37M |
VRE vs WELL vs EQR vs AVB vs UDR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Veris Residential, … (VRE) | 100 | 124.7 | +24.7% |
| Welltower Inc. (WELL) | 100 | 420.4 | +320.4% |
| Equity Residential (EQR) | 100 | 108.8 | +8.8% |
| AvalonBay Communiti… (AVB) | 100 | 119.1 | +19.1% |
| UDR, Inc. (UDR) | 100 | 99.9 | -0.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VRE vs WELL vs EQR vs AVB vs UDR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VRE ranks third and is worth considering specifically for growth exposure.
- Rev growth 6.4%, EPS growth 420.0%, 3Y rev CAGR 7.3%
- Lower P/E (23.7x vs 50.6x)
WELL carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 223.1% 10Y total return vs AVB's 31.6%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- Beta 0.13, yield 1.3%, current ratio 5.34x
- 35.8% FFO/revenue growth vs UDR's 2.4%
Among these 5 stocks, EQR doesn't own a clear edge in any measured category.
AVB is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- 34.6% margin vs WELL's 12.3%
- 4.8% ROA vs WELL's 2.3%, ROIC 3.3% vs 0.5%
UDR is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 15 yrs, beta 0.39, yield 4.6%
- PEG 1.60 vs EQR's 9.94
- 4.6% yield, 15-year raise streak, vs VRE's 1.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs UDR's 2.4% | |
| Value | Lower P/E (23.7x vs 50.6x) | |
| Quality / Margins | 34.6% margin vs WELL's 12.3% | |
| Stability / Safety | Beta 0.13 vs AVB's 0.48, lower leverage | |
| Dividends | 4.6% yield, 15-year raise streak, vs VRE's 1.7% | |
| Momentum (1Y) | +42.7% vs UDR's -9.5% | |
| Efficiency (ROA) | 4.8% ROA vs WELL's 2.3%, ROIC 3.3% vs 0.5% |
VRE vs WELL vs EQR vs AVB vs UDR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VRE vs WELL vs EQR vs AVB vs UDR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AVB leads in 1 of 6 categories
WELL leads 1 • UDR leads 1 • VRE leads 0 • EQR leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AVB leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 40.0x VRE's $291M. AVB is the more profitable business, keeping 34.6% of every revenue dollar as net income compared to WELL's 12.3%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $291M | $11.6B | $3.1B | $3.0B | $1.7B |
| EBITDAEarnings before interest/tax | $129M | $2.8B | $1.9B | $1.8B | $1.1B |
| Net IncomeAfter-tax profit | $70M | $1.4B | $954M | $1.1B | $491M |
| Free Cash FlowCash after capex | $50M | $2.5B | $1.3B | $1.5B | $892M |
| Gross MarginGross profit ÷ Revenue | +23.4% | +39.1% | +46.3% | +67.0% | +46.0% |
| Operating MarginEBIT ÷ Revenue | +14.7% | +4.4% | +28.5% | +30.1% | +27.4% |
| Net MarginNet income ÷ Revenue | +24.2% | +12.3% | +30.6% | +34.6% | +28.6% |
| FCF MarginFCF ÷ Revenue | +17.1% | +21.9% | +42.7% | +49.7% | +52.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.5% | +40.3% | +2.5% | +3.7% | +0.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -36.4% | +22.5% | -64.2% | -40.9% | +147.8% |
Valuation Metrics
Evenly matched — VRE and EQR and AVB each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 22.6x trailing earnings, EQR trades at a 85% valuation discount to WELL's 153.3x P/E. Adjusting for growth (PEG ratio), UDR offers better value at 0.79x vs AVB's 5.37x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.8B | $149.2B | $24.7B | $25.8B | $12.0B |
| Enterprise ValueMkt cap + debt − cash | $3.1B | $165.6B | $33.4B | $35.0B | $18.2B |
| Trailing P/EPrice ÷ TTM EPS | 23.71x | 153.25x | 22.63x | 25.14x | 32.69x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 78.42x | 50.61x | 37.72x | 66.06x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 4.44x | 5.37x | 0.79x |
| EV / EBITDAEnterprise value multiple | 23.09x | 66.40x | 15.61x | 19.15x | 18.15x |
| Price / SalesMarket cap ÷ Revenue | 6.17x | 13.99x | 7.96x | 8.51x | 7.03x |
| Price / BookPrice ÷ Book value/share | 1.52x | 3.35x | 2.24x | 2.23x | 2.95x |
| Price / FCFMarket cap ÷ FCF | 32.39x | 52.41x | 19.13x | 18.28x | 19.61x |
Profitability & Efficiency
Evenly matched — VRE and EQR each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
UDR delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $3 for WELL. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to UDR's 1.49x. On the Piotroski fundamental quality scale (0–9), VRE scores 7/9 vs AVB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.6% | +3.5% | +8.4% | +8.8% | +12.4% |
| ROA (TTM)Return on assets | +2.5% | +2.3% | +4.6% | +4.8% | +4.7% |
| ROICReturn on invested capital | +1.3% | +0.5% | +4.2% | +3.3% | +2.3% |
| ROCEReturn on capital employed | +2.0% | +0.6% | +5.7% | +4.4% | +3.1% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 6 | 5 | 7 |
| Debt / EquityFinancial leverage | 1.07x | 0.49x | 0.77x | 0.79x | 1.49x |
| Net DebtTotal debt minus cash | $1.4B | $16.3B | $8.7B | $9.1B | $6.2B |
| Cash & Equiv.Liquid assets | $14M | $5.0B | $56M | $187M | $37M |
| Total DebtShort + long-term debt | $1.4B | $21.4B | $8.8B | $9.3B | $6.2B |
| Interest CoverageEBIT ÷ Interest expense | 1.84x | 0.26x | 5.58x | 5.07x | — |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $9,739 for UDR. Over the past 12 months, WELL leads with a +42.7% total return vs UDR's -9.5%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs UDR's 0.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +28.4% | +14.3% | +8.4% | +3.9% | +3.0% |
| 1-Year ReturnPast 12 months | +22.8% | +42.7% | -2.7% | -7.2% | -9.5% |
| 3-Year ReturnCumulative with dividends | +21.5% | +189.5% | +17.5% | +14.4% | +1.9% |
| 5-Year ReturnCumulative with dividends | +16.8% | +202.3% | +6.7% | +12.1% | -2.6% |
| 10-Year ReturnCumulative with dividends | -12.8% | +223.1% | +29.3% | +31.6% | +38.8% |
| CAGR (3Y)Annualised 3-year return | +6.7% | +42.5% | +5.5% | +4.6% | +0.6% |
Risk & Volatility
Evenly matched — VRE and WELL each lead in 1 of 2 comparable metrics.
Risk & Volatility
WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than AVB's 0.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VRE currently trades 99.7% from its 52-week high vs UDR's 85.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.22x | 0.13x | 0.38x | 0.48x | 0.39x |
| 52-Week HighHighest price in past year | $19.03 | $219.59 | $71.80 | $209.86 | $43.12 |
| 52-Week LowLowest price in past year | $13.69 | $142.65 | $57.58 | $160.09 | $32.94 |
| % of 52W HighCurrent price vs 52-week peak | +99.7% | +97.0% | +91.7% | +88.5% | +85.7% |
| RSI (14)Momentum oscillator 0–100 | 66.3 | 60.2 | 69.8 | 71.2 | 64.9 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 2.6M | 2.4M | 940K | 3.2M |
Analyst Outlook
UDR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VRE as "Hold", WELL as "Buy", EQR as "Hold", AVB as "Hold", UDR as "Buy". Consensus price targets imply 9.0% upside for UDR (target: $40) vs -26.2% for VRE (target: $14). For income investors, UDR offers the higher dividend yield at 4.64% vs WELL's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $14.00 | $226.50 | $70.15 | $191.70 | $40.25 |
| # AnalystsCovering analysts | 12 | 34 | 46 | 42 | 38 |
| Dividend YieldAnnual dividend ÷ price | +1.7% | +1.3% | +4.1% | +3.8% | +4.6% |
| Dividend StreakConsecutive years of raises | 3 | 2 | 8 | 3 | 15 |
| Dividend / ShareAnnual DPS | $0.32 | $2.76 | $2.69 | $6.99 | $1.72 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | 0.0% | +1.1% | +1.9% | +1.0% |
AVB leads in 1 of 6 categories (Income & Cash Flow). WELL leads in 1 (Total Returns). 3 tied.
VRE vs WELL vs EQR vs AVB vs UDR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VRE or WELL or EQR or AVB or UDR a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 2. 4% for UDR, Inc. (UDR). Equity Residential (EQR) offers the better valuation at 22. 6x trailing P/E (50. 6x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VRE or WELL or EQR or AVB or UDR?
On trailing P/E, Equity Residential (EQR) is the cheapest at 22.
6x versus Welltower Inc. at 153. 3x. On forward P/E, AvalonBay Communities, Inc. is actually cheaper at 37. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: UDR, Inc. wins at 1. 60x versus Equity Residential's 9. 94x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — VRE or WELL or EQR or AVB or UDR?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -2. 6% for UDR, Inc. (UDR). Over 10 years, the gap is even starker: WELL returned +223. 1% versus VRE's -12. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VRE or WELL or EQR or AVB or UDR?
By beta (market sensitivity over 5 years), Welltower Inc.
(WELL) is the lower-risk stock at 0. 13β versus AvalonBay Communities, Inc. 's 0. 48β — meaning AVB is approximately 262% more volatile than WELL relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 149% for UDR, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VRE or WELL or EQR or AVB or UDR?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 2. 4% for UDR, Inc. (UDR). On earnings-per-share growth, the picture is similar: Veris Residential, Inc. grew EPS 420. 0% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VRE or WELL or EQR or AVB or UDR?
Equity Residential (EQR) is the more profitable company, earning 36.
1% net margin versus 8. 8% for Welltower Inc. — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EQR leads at 36. 3% versus 3. 3% for WELL. At the gross margin level — before operating expenses — AVB leads at 67. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VRE or WELL or EQR or AVB or UDR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, UDR, Inc. (UDR) is the more undervalued stock at a PEG of 1. 60x versus Equity Residential's 9. 94x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, AvalonBay Communities, Inc. (AVB) trades at 37. 7x forward P/E versus 78. 4x for Welltower Inc. — 40. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UDR: 9. 0% to $40. 25.
08Which pays a better dividend — VRE or WELL or EQR or AVB or UDR?
All stocks in this comparison pay dividends.
UDR, Inc. (UDR) offers the highest yield at 4. 6%, versus 1. 3% for Welltower Inc. (WELL).
09Is VRE or WELL or EQR or AVB or UDR better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +223. 1% 10Y return). Both have compounded well over 10 years (WELL: +223. 1%, AVB: +31. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VRE and WELL and EQR and AVB and UDR?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VRE is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock; EQR is a mid-cap income-oriented stock; AVB is a mid-cap income-oriented stock; UDR is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.